Early Mpox Antiviral Shows Promise in HIV Patients
Widespread tecovirimat use raises concerns of resistance. Mpox appears less severe in healthy individuals with HIV.
Source: medindia.net
Stay updated with breaking news from Bruce Aldred. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Widespread tecovirimat use raises concerns of resistance. Mpox appears less severe in healthy individuals with HIV.
New findings support starting tecovirimat treatment at the time of suspected mpox diagnosis in all people with HIV.
New York, January 9 (IANS) Using antiviral tecovirimat (Tpoxx) within 7 days of mpox symptom onset is associated with lower rates of mpox disease progression among people with HIV (PWH), according to a study.